Ftse Mib
33.863,39
1,14%
DAX
20.016,75
0,55%
S&P 500
6.044,46
-0,04%
NASDAQ
19.405,57
0,01%
Bitcoin
95.577,43
-0,29%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Appili Therapeutics Inc (APLI) Appili Therapeutics Inc (APLI) Notizie

Appili Therapeutics Inc

APLI
0,035
0,00 (0,00%)
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: Toronto
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
19/11/202413:17GLOBEAppili Therapeutics Announces Receipt of Final Court Order..
14/11/202413:15GLOBEAppili Therapeutics Reports Financial and Operational..
08/11/202414:30BWAditxt Provides Update on Equity Line of Credit, ATM Usage,..
07/11/202414:30BWAditxt’s Target Acquisition Appili Therapeutics Announces..
06/11/202423:55GLOBEAppili Therapeutics Announces Results of Special Meeting of..
06/11/202414:30BWAditxt Acquisition Target Evofem Biosciences Secures..
31/10/202418:00APSBiopharma Bucking Market Trends on Positive FDA Feedback
31/10/202413:30BWAditxt’s Target Acquisition Appili Therapeutics Announces..
31/10/202412:15GLOBEAppili Therapeutics Announces Alignment with FDA on..
30/10/202422:00BWAditxt To Host Virtual Stakeholder Update and Q&A Session on..
29/10/202413:15BWSylvia Hermina Joins Aditxt’s Board of Directors, Elevating..
28/10/202413:15BWAditxt Completes Final Equity Investment and Key Milestone..
17/10/202413:15GLOBEAppili Therapeutics Presents Update on ATI-1701 Biodefense..
10/10/202421:40GLOBEAppili Therapeutics – Press Release Correction
10/10/202414:15BWAditxt’s Acquisition Target Appili Therapeutics Will Hold a..
10/10/202413:13GLOBEAppili Therapeutics Announces Mailing of the Management..
03/10/202414:15BWAditxt Delivers Shareholder Update and 2024 Year-End Plan
17/9/202423:11GLOBEAppili Therapeutics Announces Results of Annual and Special..
29/8/202414:15BWAditxt to Present at the H.C. Wainwright 26th Annual Global..
21/8/202414:15BWAditxt Announces Third Amendment to Arrangement Agreement..
21/8/202413:15GLOBEAppili Therapeutics Announces Third Amendment to Arrangement..
13/8/202423:19GLOBEAppili Therapeutics Reports Financial and Operational..
25/7/202414:30BWAditxt Signs Second Amendment to the Arrangement Agreement..
18/7/202423:07GLOBEAppili Therapeutics Announces Second Amendment to..
02/7/202413:33GLOBEAppili Therapeutics Announces Amendment to Arrangement..
25/6/202423:46GLOBEAppili Therapeutics Reports Fiscal Year 2024 Financial and..
27/4/202401:03GLOBEAppili Therapeutics Announces Additional Bridge Loan from ..
02/4/202414:30BWAditxt Signs a Definitive Agreement to Acquire Appili..
02/4/202413:30GLOBEAppili Therapeutics Signs Definitive Agreement to be..
12/3/202412:12GLOBEResearchers Publish Manuscript on the Prevention and..
13/2/202423:49GLOBEAppili Therapeutics Reports Financial and Operational..
15/12/202313:27BWAppili Therapeutics Announces Issuance of Patent for..
Apertura: 0,035 Min: 0,035 Max: 0,035
Chiusura: 0,035

La tua Cronologia

TSX
APLI
Appili Therapeutics
EU
PHIA
Koninklijke Philips NV
BMF
INKFUT
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network